Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit® E PO
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit® E PO. / Doreth, Maria; Löbmann, Korbinian; Grohganz, Holger; Holm, René; Lopez De Diego, Heidi; Rades, Thomas; Priemel, Petra A.
In: Journal of Drug Delivery Science and Technology, Vol. 34, 01.02.2016, p. 32–40.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Glass solution formation in water - In situ amorphization of naproxen and ibuprofen with Eudragit® E PO
AU - Doreth, Maria
AU - Löbmann, Korbinian
AU - Grohganz, Holger
AU - Holm, René
AU - Lopez De Diego, Heidi
AU - Rades, Thomas
AU - Priemel, Petra A.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Previously, the concept of in situ amorphization of indomethacin/Eudragit® E compacts was introduced. In the current study, in situ amorphization of naproxen and ibuprofen with Eudragit® E was investigated to gain a better understanding of in situ amorphization and to investigate if this approach is applicable to other drugs. Compacts of drug and Eudragit® E were compressed at a 2:1, 1:1 and 1:2 drug-to-polymer ratio (w/w) and immersed in water for 1 h. Physicochemical characteristics, potential interactions and dissolution behavior were analyzed and compared to non-immersed compacts.Both drugs formed a glass solution with Eudragit® E when immersed into water. In XRPD, reflections of the respective drugs decreased or disappeared completely. All samples showed a single glass transition temperature in the DSC, suggesting the formation of single phase amorphous systems. Ionic interactions between drug and polymer were identified by infrared spectroscopy. In the dissolution study (pH 4.1), especially the 1:1 (w/w) in situ amorphized samples showed an improved dissolution behavior compared to their non-immersed counterparts. It can be concluded that in situ amorphization is a promising method to amorphize poorly water-soluble drugs immediately prior to administration, and thereby avoid the physical stability problems connected to amorphous formulations during storage.
AB - Previously, the concept of in situ amorphization of indomethacin/Eudragit® E compacts was introduced. In the current study, in situ amorphization of naproxen and ibuprofen with Eudragit® E was investigated to gain a better understanding of in situ amorphization and to investigate if this approach is applicable to other drugs. Compacts of drug and Eudragit® E were compressed at a 2:1, 1:1 and 1:2 drug-to-polymer ratio (w/w) and immersed in water for 1 h. Physicochemical characteristics, potential interactions and dissolution behavior were analyzed and compared to non-immersed compacts.Both drugs formed a glass solution with Eudragit® E when immersed into water. In XRPD, reflections of the respective drugs decreased or disappeared completely. All samples showed a single glass transition temperature in the DSC, suggesting the formation of single phase amorphous systems. Ionic interactions between drug and polymer were identified by infrared spectroscopy. In the dissolution study (pH 4.1), especially the 1:1 (w/w) in situ amorphized samples showed an improved dissolution behavior compared to their non-immersed counterparts. It can be concluded that in situ amorphization is a promising method to amorphize poorly water-soluble drugs immediately prior to administration, and thereby avoid the physical stability problems connected to amorphous formulations during storage.
U2 - 10.1016/j.jddst.2016.02.003
DO - 10.1016/j.jddst.2016.02.003
M3 - Journal article
VL - 34
SP - 32
EP - 40
JO - Journal of Drug Delivery Science and Technology
JF - Journal of Drug Delivery Science and Technology
SN - 1773-2247
ER -
ID: 162186325